1.1.1.41	isocitrate dehydrogenase (NAD+)	esophageal cancer cell	-	712180	
1.1.1.42	isocitrate dehydrogenase (NADP+)	esophageal cancer cell	-	712180	
1.2.1.3	aldehyde dehydrogenase (NAD+)	esophageal cancer cell	-	697569	
1.4.3.13	protein-lysine 6-oxidase	esophageal cancer cell	-	686947	
2.1.1.63	methylated-DNA-[protein]-cysteine S-methyltransferase	esophageal cancer cell	esophageal squamous cell carcinoma	658938	
2.4.1.221	peptide-O-fucosyltransferase	esophageal cancer cell	upregulated in esophageal cancer stem-like cell in comparison to adherent cells	759318	
2.4.2.4	thymidine phosphorylase	esophageal cancer cell	patients with PD-ECGF/TP-positive tumors have a poorer prognosis than those with negative tumors	673635	
2.7.1.40	pyruvate kinase	esophageal cancer cell	-	673438	
2.7.11.21	polo kinase	esophageal cancer cell	is highly expressed, on average 2.7-fold higher mRNA expression levels than in normal organs excluding testis, promoter activity 18.9 higher than in normal lung and renal cells	677916	
2.7.12.2	mitogen-activated protein kinase kinase	esophageal cancer cell	-	740944	
3.4.14.5	dipeptidyl-peptidase IV	esophageal cancer cell	-	703678	
3.4.24.B3	matrix metalloproteinase-11	esophageal cancer cell	ST-3+/TIMP-2- (stromelysin-3+/matrix metalloproteinase TIMP-2)-phenotype is an adverse prognosticator in esophageal cancer patients	670451	
3.4.24.B5	matrix metalloproteinase-15	esophageal cancer cell	-	754240	
3.4.24.B7	matrix metalloproteinase-26	esophageal cancer cell	-	710794	
6.3.4.3	formate-tetrahydrofolate ligase	esophageal cancer cell	-	765141